Lingohr & Partner Asset Management Gmb H Abb Vie Inc. Transaction History
Lingohr & Partner Asset Management Gmb H
- $55.2 Million
- Q2 2025
A detailed history of Lingohr & Partner Asset Management Gmb H transactions in Abb Vie Inc. stock. As of the latest transaction made, Lingohr & Partner Asset Management Gmb H holds 2,351 shares of ABBV stock, worth $450,263. This represents 0.79% of its overall portfolio holdings.
Number of Shares
2,351
Previous 24,855
90.54%
Holding current value
$450,263
Previous $5.16 Million
91.55%
% of portfolio
0.79%
Previous 1.29%
Shares
6 transactions
Others Institutions Holding ABBV
# of Institutions
4,271Shares Held
1.27BCall Options Held
18.2MPut Options Held
15.5M-
Vanguard Group Inc Valley Forge, PA174MShares$33.3 Billion0.68% of portfolio
-
Black Rock Inc. New York, NY136MShares$26.1 Billion0.54% of portfolio
-
State Street Corp Boston, MA80MShares$15.3 Billion0.71% of portfolio
-
Jpmorgan Chase & CO New York, NY54.8MShares$10.5 Billion0.9% of portfolio
-
Morgan Stanley New York, NY41.1MShares$7.88 Billion0.63% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $339B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...